Oxyplastin

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Oxyplastin

Oxyplastin is a specialized topical dermatological monopreparation containing Zinc Oxide (ZnO), classified pharmacologically as a Topical Protective Agent and mild Astringent. It is formulated as a specific paste for cutaneous application. Unlike lighter creams, its dense composition ensures prolonged adherence and mechanical defense on the skin's surface.


Quick Facts

Property Description
Active ingredient Zinc Oxide (ZnO)
Form Paste (highly viscous semi-solid)
Pharmacological Class Topical Protective Agent and Astringent
Common Use Protection from irritation and moisture
Origin Inorganic substance (Zinc Oxide)

Classification, Composition, and General Purpose

Oxyplastin is pharmacologically categorized as a Topical Protective Agent and mild Astringent, a class of medicines used to shield and soothe superficial skin issues. The Zinc Oxide active ingredient is an inorganic substance utilized extensively in topical preparations. This means the product is primarily a physical defense.

The preparation takes the specialized form of a paste, which differs from lighter creams or ointments by suspending a high concentration of the active solid within a fatty base or hydrophobic vehicle (such as petrolatum or oils). This formulation, clinically recognized for its role in preventing surface breakdown, results in a dense, cohesive consistency that establishes a tenacious, water-repellent film on the skin.

The general purpose of Oxyplastin is to protect and relieve skin from continuous external irritation, friction, and environmental aggressors. The preparation works by establishing a robust, physical barrier that mechanically isolates the affected area. Concurrently, the astringent properties of the Zinc Oxide provide a gentle drying action, assisting in the management of excessive surface moisture and promoting a more conducive environment for the skin’s natural repair mechanisms.

What side effects are possible with Oxyplastin?

Possible Side Effects and Safety Information

The safety profile of Oxyplastin, a topical Zinc Oxide paste, is consistent with its classification as a non-systemic Topical Protective Agent. The documented adverse reactions are overwhelmingly confined to local effects at the site of application, reflecting a restriction to Skin and subcutaneous tissue disorders in regulatory classifications.


Documented Adverse Reactions

The most frequently discussed adverse reactions in regulatory documents, such as skin rash, local irritation, hives, or itching, are typically classified as having an Incidence Not Known (Frequency Not Established) in post-marketing reports. This classification is common for long-established topical ingredients where the true rate of occurrence cannot be reliably quantified from available data.

Adverse Reaction Type Classification Focus
Local Reactions Irritation, burning, stinging, or pruritus (itching)
System-Organ Class Skin and subcutaneous tissue disorders

Serious Reactions and Safety Constraints

While rare, the official labeling for topical agents includes the possibility of severe allergic-type reactions, such as a severe rash or swelling of the face, lips, or throat, which represent significant local hypersensitivity. This forms the basis of the most serious safety consideration for external preparations.

Official regulatory documents emphasize specific constraints on use. The product is strictly For External Use Only. Contact must be avoided with eyes and mucous membranes to prevent severe local irritation. Furthermore, the label covers use in the pediatric population (infants) given its primary indication for diaper rash, with no specialized safety constraints typically listed for older adults or those with renal or hepatic impairment due to minimal systemic absorption.

Overdose and Emergency Response

The regulatory overdose profile for this topical preparation is defined almost exclusively by the risk of accidental oral ingestion. Due to minimal systemic absorption through the skin, topical overdose is officially classified as unlikely. The primary instruction mandated by regulatory authorities is to seek immediate medical help or contact a Poison Control Center right away if the paste is swallowed. The official guidance to keep out of reach of children addresses the main population at risk for this accidental exposure pathway.

Overdose Scope Official Regulatory Information
Documented Manifestations Overdose symptoms following ingestion may include gastrointestinal distress, such as vomiting, diarrhea, stomach pain, and inflammation of the mouth, along with systemic signs like fever, weakness, and cold sweats.
Severe Outcomes Documented complications requiring symptomatic treatment include systemic acidosis, circulatory failure, and pulmonary oedema.
Supportive Management Treatment is consistently defined as symptomatic and supportive. Procedures such as gastric lavage or the administration of activated charcoal may be considered in acute ingestion scenarios.
Monitoring Official guidance advises monitoring of vital signs (pulse, blood pressure) and may require diagnostic tests, including blood work and an ECG, to assess systemic impact.

Regulatory documents generally classify the active ingredient as not very poisonous if it is eaten, and the prognosis for long-term recovery is considered highly likely.

Therapeutic Uses of Oxyplastin

What Oxyplastin Treats: Main Uses and Benefits

Therapeutic Focus and Relief

The therapeutic application of Oxyplastin is relevant in contexts marked by increased discomfort or tension, and the need for a protective, physical barrier. It is commonly used when symptoms are related to inflammatory or irritative states.

Oxyplastin is commonly used in conditions characterized by periods of heightened symptoms such as diaper rash (nappy dermatitis) and Incontinence-Associated Dermatitis (IAD). It is also relevant for easing symptoms related to chafing, minor superficial abrasions, and irritative states. The paste is applied across domains where additional symptomatic support is needed, and is relevant when symptoms are related to physical discomfort.

This application provides support that contributes to easing the overall symptom load associated with discomfort. The dense formulation contributes to improved comfort and supports the skin's defense against the potential for further breakdown. It assists with managing symptoms that interfere with daily functioning.

Quick Fact

Quick Fact: Relief for Irritated Skin Discomfort
Symptom Domains Redness, soreness, chafing, and symptoms that create noticeable physiological strain
Primary Benefit Provides a physical barrier and supportive relief
Target Conditions Diaper rash, IAD, and minor skin trauma

Regulatory References

  1. DailyMed (NIH) description of Zinc Oxide uses

Eligibility and Restrictions for Use

This section outlines the official eligibility and non-eligibility rules for Oxyplastin (presumed to be Oxaliplatin), as defined by major governmental regulatory agencies.

Populations Who Must Not Use Oxyplastin (Contraindications)

The following groups are explicitly prohibited from using this medicine according to official regulatory labeling:

  • Hypersensitivity: Individuals with a documented history of allergy or hypersensitivity reaction to Oxyplastin itself or to other platinum-based drugs (such as cisplatin or carboplatin).
  • Pregnancy and Lactation: Use is contraindicated in pregnancy due to the potential for fetal harm. Breastfeeding is also contraindicated during treatment and for a period after the final dose.

Eligibility Restrictions and Special Considerations

Population/Condition Official Regulatory Status
Pediatric Use Safety and effectiveness have not been established in children and adolescents.
Severe Renal Impairment Patients with creatinine clearance less than 30 mL/ min require an initial dose reduction to be eligible for treatment.
Neuropathy Patients with a pre-existing peripheral sensory neuropathy with functional impairment (Grade 2 or higher) prior to therapy may be ineligible or require dose adjustment.
Severe Toxicity The drug must be permanently discontinued upon the confirmed diagnosis of conditions such as Posterior Reversible Encephalopathy Syndrome (PRES), Interstitial Lung Disease (ILD), or persistent, severe (Grade 3 or 4) neuropathy.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of topical Zinc Oxide (Oxyplastin) is primarily characterized by physicochemical incompatibilities and local administration restrictions, as its mechanism is limited to the skin surface. Due to minimal to negligible systemic absorption after cutaneous application, regulatory documents do not specify known systemic pharmacokinetic interactions, such as those related to CYP enzymes or drug transporters, typically associated with oral medicines.

Official Interaction Statements

Interaction Type Interacting Substance/Condition Regulatory Outcome
Chemical Incompatibility Benzylpenicillin Formal documentation of incompatibility; must not be co-administered or mixed.
Physicochemical Reaction Fatty acids in oils and fats Documented reaction noted in regulatory stability information.
Local Interference Other topical skin products Co-application at the same site may compromise the physical barrier action of the paste.

No timing-based separation requirements are documented in regulatory labeling for the avoidance of systemic interactions. The absence of documented systemic exposure also means that no population-specific interaction considerations (e.g., for hepatic impairment) are noted in official prescribing information.

Mechanism of Action

Physical Isolation and Dermal Barrier Enhancement

Oxyplastin exerts a local, dual-mechanism, initiated by the physical isolation provided by its hydrophobic paste vehicle and the chemical activity of Zinc Oxide ( ZnO). The paste forms a continuous film over the stratum corneum, acting as a non-systemic physical blockade. This action instantly isolates the underlying tissue from external irritants and excess moisture, influencing the continuation of frictional and irritant effects at the tissue surface.

Local Cytokine Modulation and Astringent Action

In the presence of moisture, the ZnO releases divalent zinc ions ( Zn^2+). These ions primarily modulate keratinocyte signaling, reducing the release of pro-inflammatory cytokines (such as IL-1alpha) to attenuate local cytokine-mediated signaling. Concurrently, Zn^2+ induces astringency by causing superficial protein precipitation, which enables tissue desiccation and limits the accumulation of tissue fluid.

Engagement of Epithelial Regeneration Pathways

Beyond surface protection, the Zinc Oxide mechanism engages the molecular pathway for epithelial restoration. The local presence of Zn^2+ acts as a metabolic cofactor, stimulating basal cell mitosis and differentiation. This key step functions as a necessary cofactor for enzymes involved in re-epithelialization and influences the formation of complete epidermal structure.

Dosage and Administration Information

Oxyplastin is a topical preparation that must be used strictly according to the administration guidelines. As a highly concentrated paste containing Zinc Oxide, its proper function is dependent on a correct procedural sequence and application frequency, regardless of the age of the patient.

Administration Scope

Feature Official Labeled Instruction
Route of Administration Topical (Cutaneous). The product is restricted to external use only.
Dosing Schedule Apply the paste liberally to ensure the entire affected area is covered with a protective layer.
Frequency and Schedule Use as often as necessary (PRN), particularly with each change of wet or soiled material. Application is recommended at bedtime or any time when prolonged exposure to wetness may occur.
Age-Group Rules The same regimen of applying the paste as needed is specified for both adults and children.

Official Procedural Steps

The instructions define a specific sequence for application to maintain the integrity of the barrier:

  1. Change the wet or soiled material promptly.
  2. Cleanse the skin area.
  3. Allow the area to dry completely.
  4. Apply the paste liberally to the affected area.

This protocol establishes a non-scheduled usage pattern where the frequency is determined by the need to immediately establish and maintain the physical barrier against external conditions. The continuous use of the product should be maintained until the protective need ends, though the usage instructions advise consulting a professional if the condition does not improve within seven days.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Oxyplastin

Oxyplastin (Zinc Oxide paste) was studied for whether it was associated with changes in symptoms and prevention of diaper rash in conditions characterized by irritative states and physical discomfort. The research base is primarily composed of Randomized Controlled Trials (RCTs) and systematic reviews.


Evidence for use in Diaper Rash (Diaper Dermatitis)

Research has explored the use of the paste in conditions characterized by periods of heightened symptoms such as diaper rash. Short-term RCTs and systematic reviews were evaluated in infants and young children who presented with mild to moderate symptoms. The studies examined outcomes related to physical discomfort, specifically measuring changes in dermatitis severity scores and the duration of lesion resolution. Findings describe patterns observed in the populations over the short follow-up durations examined, often less than one week.

Evidence for use in Incontinence-Associated Dermatitis (IAD)

The use of Zinc Oxide paste was evaluated in a different population for conditions involving periods of heightened symptoms, specifically Incontinence-Associated Dermatitis (IAD). Studies were observed in hospitalized adults and older children, often elderly patients, who were incontinent and receiving structured care. These trials examined outcomes related to skin integrity, measuring changes in IAD severity scores and the percentage of participants whose symptoms moved towards a state of full resolution.


Understanding Research Gaps and Uncertainty

Research highlights what is known, but also what is still uncertain. The follow-up durations were limited in most acute treatment trials, meaning the full picture of long-term effects are not fully established. Also, for IAD studies, variability was observed in the findings obtained from clinical settings where the paste was used alongside multiple other skin care interventions, which introduces complexity when trying to understand the paste’s specific role. Comparative evidence against an inert control is lacking in many high-quality trials, which instead often compare one active product against another. Certainty remains low for outcomes outside the acute treatment phase.

Key Studies & References

  1. Incontinence-associated dermatitis (IAD) study: Blinded assessment and treatment with zinc oxide-based ointment (RCT comparing Calmoseptine and Desitin)
  2. Elucidating the role of zinc oxide in dermatitis of varied etiology across the age spectrum: a comprehensive review

Frequently Asked Questions (FAQ)

Common questions about Oxyplastin (FAQ)

Q: Is Oxyplastin used for pain or inflammation?

A: Official information describes Oxyplastin’s action as helping to attenuate local cytokine-mediated signaling in the skin, which is related to reducing inflammation. The product is primarily indicated for protection and relief from external irritation, and its official purpose is not defined as a systemic pain reliever.

Q: Can Oxyplastin make you feel sleepy?

A: Official labels do not list sleepiness or drowsiness as a known or expected side effect for this product. Since Oxyplastin is designed to act only on the skin surface with minimal absorption into the body, systemic effects of this nature are not expected.

Q: If I miss a dose of Oxyplastin, what happens?

A: Because Oxyplastin is a topical protective paste used as needed (PRN), there are no instructions in the official labeling regarding the management of a 'missed dose' or application. The product is used only when the protective barrier is needed.

Q: Can I take Oxyplastin if I have a history of kidney problems?

A: Due to the minimal to negligible systemic absorption of this topical product, official prescribing information does not generally contain specialized safety constraints for individuals with kidney or liver impairment. Very little of the medicine enters the bloodstream.

Q: Does taking Oxyplastin mean I can't drive?

A: Official warnings and precautions do not include restrictions regarding driving, as the product is not associated with central nervous system effects. Due to its minimal systemic absorption, it is not expected to cause dizziness or impaired concentration.

Q: Why is Oxyplastin sometimes given in combination with other treatments?

A: Research indicates that the product may be used in combination with other interventions as part of a structured skin care regimen. This is because Oxyplastin is classified as a skin protectant that establishes a physical barrier, which complements other treatments for conditions like incontinence-associated dermatitis.

Q: Are there any common foods or drinks I need to avoid while on Oxyplastin?

A: Official labeling for Oxyplastin does not specify any dietary or food restrictions that need to be avoided during its use. This is consistent with its classification as a topical product that is not intended to be ingested.

Q: Does Oxyplastin interact with common over-the-counter cold medicines?

A: Due to its mechanism being limited to the skin surface, no systemic pharmacokinetic interactions with oral medicines, such as over-the-counter cold medicines, are specified in the official labeling.

Q: Is it normal to have mild nausea when starting Oxyplastin?

A: Nausea is not listed as a commonly observed adverse reaction for this topical protective agent. The adverse reactions documented in official sources are primarily confined to local effects at the application site, such as mild irritation or itching.

Q: How does Oxyplastin affect blood pressure?

A: Due to minimal systemic absorption, the product is not expected to have any effect on systemic metrics like blood pressure. Oxyplastin is a topical paste designed to act locally on the skin surface.

Q: Can I use Oxyplastin if I am already taking herbal supplements?

A: Official regulatory information does not specify any known interactions between topical zinc oxide and herbal supplements. If other topical products are co-applied at the same site, this may compromise the paste's physical barrier action.

Q: Is there a generic version of Oxyplastin available?

A: The active ingredient in Oxyplastin, Zinc Oxide paste, is an inorganic substance utilized extensively in topical preparations. It is a common ingredient found in numerous over-the-counter (OTC) skin protectant products.

Q: Does Oxyplastin change the way my liver works?

A: Since the systemic absorption of the product is minimal to negligible, hepatic (liver) function is not expected to be affected by the use of this topical paste.

Q: Does Oxyplastin have any known interactions with birth control pills?

A: Official labeling for Oxyplastin does not specify any interactions with oral systemic medications, such as birth control pills. This is due to the product having minimal to negligible absorption into the bloodstream.

Q: How quickly does the effect of Oxyplastin wear off?

A: The protective effect of Oxyplastin lasts until the physical barrier is compromised by external conditions. Regulatory instructions require reapplication as often as necessary, specifically with each change of wet or soiled material, to maintain continuous protection.

Q: Is it okay to take Oxyplastin with antacids?

A: Official labeling does not specify any interactions between the topical paste and oral systemic medications such as antacids. The product is only for external use, and systemic absorption is minimal.

Q: Can Oxyplastin affect my sleep patterns?

A: Sleep pattern changes are not listed as a known or expected systemic adverse reaction for this topical protective agent, as the product acts locally and is not intended to produce systemic effects.

Q: Is the medication effective for all the conditions it is approved to treat?

A: Studies have examined clinical trial outcomes for specific approved indications, such as diaper rash and incontinence-associated dermatitis. While the product is officially approved for these uses, official documents do not make a singular, global claim guaranteeing effectiveness for every individual in every approved condition.

Q: Does alcohol make the side effects of Oxyplastin worse?

A: Official labeling does not specify an interaction between topical use of the paste and alcohol consumption. The product acts locally and is not associated with systemic side effects typically exacerbated by alcohol.

Q: If Oxyplastin is stopped suddenly, are there any withdrawal symptoms described?

A: Withdrawal symptoms are not listed in regulatory documents. Since Oxyplastin is a topical, non-scheduled product with minimal systemic effects, it does not carry a risk of dependence or associated withdrawal symptoms upon discontinuation.

Q: Are there any known interactions between Oxyplastin and vaccines?

A: Official regulatory labeling does not specify any known interactions between the topical paste and vaccines.

Q: Is it common for people to stop using Oxyplastin because of side effects?

A: While local adverse reactions like irritation or itching are documented, the frequency of these side effects is often categorized as 'Incidence Not Known (Frequency Not Established)' in post-marketing reports. Therefore, official sources cannot quantify the rate at which users discontinue the product due to these effects.

Q: Is Oxyplastin described as having a low or high potential for dependence?

A: Oxyplastin is classified as a Topical Protective Agent and is not listed as a controlled substance. Official documents do not describe the product as having any potential for dependence.

Q: Are there specific laboratory tests needed while taking Oxyplastin?

A: Official regulatory documents do not require any specific laboratory monitoring tests for users of the topical product, as its effects are localized to the skin surface.

Q: Why is Oxyplastin not recommended for people with certain heart conditions?

A: The product is not restricted for use in people with heart conditions. Oxyplastin is a topical medicine with minimal systemic absorption, meaning it has little effect throughout the body.

Q: How long does it usually take for Oxyplastin to start working?

A: The paste immediately begins to work by establishing a physical barrier that offers instant isolation from external irritants and moisture. While the physical protection is immediate, the timeframe for a visible clinical benefit or wound resolution is studied over the short term (often less than one week).

Q: Is Oxyplastin a long-term medicine?

A: Oxyplastin is intended for protective use as needed to manage skin irritation. Research documents note that clinical trial follow-up durations were limited, often short-term, meaning that the full picture of any potential long-term effects are not fully established in the research evidence.

Q: Is Oxyplastin safe to use for teenagers?

A: Official administration guidelines specify the same application regimen for both adults and children. The product is used for common conditions like diaper rash in infants and young children, as well as in adults and older children for incontinence-associated dermatitis.

Q: What is the longest time a person has been studied taking Oxyplastin?

A: Research summaries note that the follow-up durations in most acute treatment trials were limited, often lasting less than one week. This highlights that studies defining the maximum duration of long-term use are not broadly available in the research literature.

Q: What is the purpose of the inactive ingredients in Oxyplastin?

A: The preparation is formulated as a dense paste using inactive ingredients, often a fatty base or hydrophobic vehicle. The role of these ingredients is to suspend the Zinc Oxide and create a cohesive, water-repellent film that acts as a physical barrier on the skin surface.

Q: What is the risk of having an allergic reaction to Oxyplastin?

A: While rare, official labeling notes the possibility of severe allergic-type reactions, such as swelling or a severe rash. However, for most local reactions like irritation or itching, the official incidence is classified as 'Frequency Not Established' in post-marketing reports, meaning the true rate of occurrence cannot be reliably quantified.

Q: Are there any published summaries of the clinical trials for Oxyplastin?

A: Research documents confirm that studies, including Randomized Controlled Trials (RCTs) and systematic reviews, were conducted for Oxyplastin. These trials examine outcomes related to dermatitis severity and lesion resolution in target populations.

Q: What is the expected timeline for improvement when using Oxyplastin?

A: The official guidance states that a healthcare professional should be consulted if the condition does not improve within seven days. Improvement in symptoms is often studied over short follow-up durations for acute conditions.

Q: Does the time of day I take Oxyplastin matter?

A: Oxyplastin is generally applied as needed (PRN), but application is specifically recommended at bedtime or any time when prolonged exposure to wetness is expected. This targeted timing helps ensure the protective barrier is maintained during periods of greatest vulnerability.

How should Oxyplastin be stored and disposed of?

How to Store and Dispose of Oxyplastin

Official regulatory guidelines strictly define the conditions necessary to store Oxyplastin paste and the correct procedures for its disposal.

Storage Requirements

Oxyplastin must be stored at a temperature not exceeding 25 °C. The product should be kept away from excessive heat and moisture and must not be frozen. To ensure product integrity, the medicine should be kept in a closed container.

Stability and Safety

This medication should not be used after the expiry date printed on the packaging. It is a mandatory requirement to store the paste out of the reach and sight of children to prevent accidental ingestion.

Disposal Instructions

Expired or unused Oxyplastin must not be thrown into household rubbish or flushed down drains. The proper disposal procedure is to ask the pharmacist or a healthcare professional for guidance. This controlled method of disposal is required to ensure environmental protection.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Oxyplastin found in:

A-Z Index: